Breast Cancer and The Hidden Connections Between Infection, Inflammation, and the Microbiome
Updated: 4 days ago

When we think about breast cancer, we often focus on genetics, hormones, environmental exposures, and lifestyle factors. However, one area receiving increasing attention in cancer research is the relationship between the gastrointestinal microbiome and breast cancer. And from a clinical perspective, I can’t stress this enough.
As you may have read in some of my other blogs, gut microbiome is a complex ecosystem of bacteria, fungi, viruses, and other microorganisms that influence digestion, immune regulation, inflammation, and hormone metabolism. When this ecosystem becomes disrupted, also known as “gut dysbiosis,” it affects the entire body, not just the digestive system.
Research suggests that changes in the gut microbiome may influence biological processes involved in breast cancer development, progression, and response to treatment and that’s why I feel compelled to continue to blog about this topic.
As an integrative oncology specialist with more than 17 years of clinical oncology experience, gut health has been an important area of focus throughout my practice. I frequently evaluate gastrointestinal function, underlying infections, beneficial bacterial populations, and markers of intestinal inflammation in patients with a history of cancer.
Over the years, I have observed recurring patterns of microbial imbalance in patients with breast cancer. These clinical observations, along with the growing scientific interest in the microbiome, have reinforced my belief that gastrointestinal health deserves greater attention in cancer care and survivorship.
The Gut Microbiome and Breast Cancer: Understanding the Connection
The relationship between the gut microbiome and breast cancer involves several interconnected biological pathways. One of the most important is the gut's influence on immune function. A substantial portion of the body's immune activity is associated with the GI tract, where microorganisms continually interact with immune cells.
Beneficial gut bacteria help regulate inflammatory responses, support the intestinal barrier, and produce chemicals that influence immune signaling throughout the body. When the microbial balance becomes disrupted, these processes can also be affected.
Researchers are continuing to investigate how gut dysbiosis may contribute to chronic inflammation, altered hormone metabolism, and changes in immune regulation that could influence breast cancer.
Underlying Gastrointestinal Infections: Why Symptoms Don't Always Tell the Whole Story
One area I pay particular attention to in clinical practice is the presence of underlying gastrointestinal infections, including pathogenic bacteria, parasites, and fungi. While some infections produce noticeable symptoms, such as diarrhea, abdominal discomfort, and bloating, others may cause relatively mild symptoms or remain asymptomatic.
When patients present with persistent gastrointestinal symptoms, identifying a potential underlying infection is an important part of my clinical assessment. Depending on their symptoms and medical history, I may recommend targeted testing for organisms such as:
• Helicobacter pylori
• Pathogenic strains of Escherichia coli
• Fusobacterium species
• Dientamoeba fragilis and other intestinal parasites
• Candida species
However, not all gastrointestinal infections produce consistent or recognizable symptoms. Some patients experience symptoms that come and go, while others may have few, if any, digestive complaints.
This is where I believe comprehensive gastrointestinal assessment can provide additional clinical insight. By evaluating potential pathogens alongside beneficial bacteria, markers of intestinal inflammation, and digestive function, advanced testing may help identify abnormalities that warrant further investigation.
Enterococcus Faecalis: An Observation in My Clinical Practice
One bacterium that has consistently attracted my attention in clinical practice is Enterococcus faecalis. Although this bacterium is a natural component of the intestinal microbiome, it has been associated with inflammatory activity, oxidative stress, and opportunistic infections.
Throughout my years of working with patients diagnosed with breast cancer, I have repeatedly observed markedly elevated intestinal levels of Enterococcus faecalis on comprehensive gastrointestinal testing in many patients I’ve evaluated. Interestingly, I have encountered this finding in patients with both estrogen and progesterone receptor positive (ER+/PR+) breast cancer and triple negative breast cancer. This observation has been particularly interesting to me because these breast cancer subtypes differ significantly in their biological characteristics and hormonal influences.
It's important to note that while I’ve repeatedly encountered this finding, it does not establish that elevated E. faecalis causes breast cancer, promotes tumor progression, or increases the risk of recurrence. This is just a clinical observation I’d like to share, which has encouraged me to pay closer attention to this organism and to the broader relationship between microbial imbalance, intestinal inflammation, and immune regulation.
Intestinal Inflammation
Inflammation is a key factor in the development and progression of cancer because inflammatory signaling can influence cellular behavior, immune function, and the surrounding tissue environment.
Calprotectin is a protein released by neutrophils, a type of white blood cell involved in the body's inflammatory response. When elevated levels are detected in the stool, it can indicate inflammation within the gastrointestinal tract.
The Importance of Beneficial Bacteria
Not all bacteria are harmful. In fact, many microorganisms residing in the gastrointestinal tract are essential to maintaining a healthy intestinal environment.
Bifidobacterium and Lactobacillus are two groups of beneficial bacteria in the microbiome, that are being heavily researched. These beneficial bacteria have several important functions, including maintaining microbial balance, supporting the intestinal barrier, processing dietary carbohydrates, and regulating immune activity.
One area included in the Comprehensive Gut Health Assessment, that I use in clinical practice, is a microbiota map. This particular part of the test maps out which beneficial bacteria is already present in the gut and which bacteria needs to be reestablished. This helps me choose the appropriate probiotics, if needed, rather than relying on a generalized probiotic formula for every patient.
The Estrobolome: How Gut Bacteria Influence Estrogen Metabolism
One of the most compelling connections between the gut microbiome and breast cancer involves estrogen metabolism. This is particularly relevant to estrogen receptor positive (ER+) breast cancer, in which estrogen can stimulate the growth of cancer cells.
The estrobolome refers to the collection of intestinal microbial genes involved in estrogen metabolism. Normally, the liver processes estrogen and prepares it for elimination. Some estrogen metabolites enter the intestines through bile and can be excreted through our stool. However, certain intestinal bacteria produce an enzyme called beta glucuronidase. This enzyme can remove glucuronic acid from conjugated estrogen metabolites, allowing some of the estrogen to be reabsorbed into the blood stream.
Short Chain Fatty Acids and Their Connection to Cancer Growth
Short chain fatty acids are compounds that are produced when our beneficial intestinal bacteria ferment dietary fiber. They include butyrate, acetate, propionate.
Butyrate is particularly important because it serves as a primary energy source for cells lining the colon and helps maintain intestinal barrier function. It also participates in inflammatory regulation and cellular signaling.
On the flip side, while acetate and propionate also play an important role in energy metabolism, immune regulation, and cellular signaling, experimental studies suggest that certain cancer cells may use acetate and propionate as an alternative energy source to support tumor growth and survival.
Intestinal Barrier Function and Immune Regulation
The intestinal lining serves as a selective barrier between the contents of the digestive tract and the rest of the body. It's made up of a thin layer of tissue called the mucosa. This protective layer allows essential nutrients, including vitamins, minerals, and fatty acids, to pass from the intestines into the bloodstream. These nutrients then nourish our tissues, organs, ligaments, tendons, and bones.
However, when the intestinal lining becomes damaged or weakened, the spaces between intestinal cells may become more permeable, allowing substances that would normally remain in the digestive tract to pass through more easily. These may include bacterial toxins, microbial components, and other potentially harmful substances.
This condition is commonly referred to as “leaky gut,” or increased intestinal permeability. When foreign substances cross the intestinal barrier, they may activate the immune system and stimulate the production of immunoglobulins (antibodies). Persistent immune activation can contribute to inflammation and immune dysregulation, processes that may also be involved in certain autoimmune diseases.
Two important markers included in this assessment are secretory immunoglobulin A (sIgA) and zonulin. Secretory IgA is an antibody involved in mucosal immune defense. It helps protect the intestinal lining against harmful microorganisms and regulates interactions between gut bacteria and the immune system. Zonulin is a protein involved in regulating intestinal permeability by influencing the tight junctions between cells lining the digestive tract.
What Can Comprehensive Gut Health Testing Reveal?
While traditional medical testing is essential for evaluating specific gastrointestinal diseases and infections, more extensive gastrointestinal assessment may provide additional information about digestive function and microbial composition.
The Comprehensive Gut Health Assessment, for example, includes testing for several categories of gastrointestinal findings.
1. Gastrointestinal Pathogens and Infections
The profile evaluates selected bacteria, viruses, parasites, and fungi that may be associated with gastrointestinal illness or microbial imbalance.
2. Beneficial and Opportunistic Bacteria
It measures selected microbial populations, including Bifidobacterium, Lactobacillus, Enterococcus, and other intestinal organisms.
3. Intestinal Inflammation
Fecal calprotectin may help identify inflammatory activity that warrants further investigation.
4. Microbial Metabolic Activity
Markers such as beta glucuronidase and short chain fatty acids provide information about selected biochemical processes occurring within the intestinal environment.
5. Digestive and Absorptive Function
Pancreatic elastase and steatocrit may provide information about pancreatic enzyme production and fat digestion.
6. Mucosal Immune Activity
Secretory IgA provides information about the intestinal immune environment.
These findings may help guide further gastrointestinal evaluation when interpreted alongside symptoms, medical history, medications, and conventional diagnostic testing.
When Should Someone with a History of Breast Cancer Consider Gut Health Assessment?
In clinical practice, I generally do not recommend this test while someone is undergoing chemotherapy, immunotherapy, or radiation, unless he/she presents with significant gastrointestinal signs and symptoms, which have not improved with appropriate treatment.
However, I believe that this assessment can be a valuable part of one’s survivorship plan and can help rebuild the body after treatment as some chemotherapies, immunotherapies, antibiotics, and targeted treatments, can alter gastrointestinal function and microbial composition. Also, some cancer treatments, like immunotherapies, can cause inflammatory conditions, including gastritis and colitis and this test can give us better insight into these conditions. Finally, this assessment may also identify underlying infection or a deficiency of beneficial bacteria, that could affect one’s immunity over a period of time.
Why Gut Health Deserves Attention for those Affected by Breast Cancer
Throughout my clinical experience, I’ve observed a strong connection between GI imbalances and my patients with breast cancer. While I can’t claim that these microbiome imbalances are the direct cause of my patient’s cancer, I strongly believe in its connection to immune signaling, inflammatory regulation, estrogen metabolism, and one’s overall health.
Click here to order the Comprehensive Gut Health Assessment.
To learn more integrative approaches to cancer care, explore the educational resources available here at Integrative Oncology Specialist.




